Nov 07, 2025 21:16
CRNX - Crinetics Pharmaceuticals, Inc.
| Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
|---|---|---|---|---|---|---|---|
| 41.91 1.09 (2.6%) | 0.02 (0.05%) | -0.12 (-0.28%) | -0.35 (-0.82%) | 0.06 (0.14%) | 1.39 (3.34%) | --- | 0.06 (0.14%) |
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
Market
Earnings & Ratios
- Basic EPS:
- -1.23
- Diluted EPS:
- -1.23
- Basic P/E:
- -34.9593
- Diluted P/E:
- -34.9593
- RSI(14) 1m:
- 37.45
- VWAP:
- 43.03
- RVol:
Events
| Period | Kind | Movement | Occurred At |
|---|
Related News
Oct 10, 2025 20:41
Sep 28, 2025 12:30
Sep 26, 2025 14:23
Sep 26, 2025 12:10
Jul 13, 2025 21:45
May 23, 2025 12:00
Feb 06, 2025 21:35
Jan 10, 2025 12:00
Jan 09, 2025 18:00